Dazodalibep Expands Horizons With Phase II Sjögren’s Syndrome Data

 
• By Alaric DeArment
  
Horizon unveiled positive Phase II data for dazodalibep in Sjögren’s syndrome • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immunological

More from Therapy Areas